Safety Issues. In order to ensure that both Parties are provided with an adequate opportunity to review safety matters, the Parties shall mutually agree after the Effective Date on procedures with respect to (i) regulatory reporting requirements, (ii) the review of Product labeling, (iii) maintenance of a safety database and (iv) other safety issues.
Appears in 5 contracts
Sources: Collaboration Agreement (Triangle Pharmaceuticals Inc), Collaboration Agreement (Triangle Pharmaceuticals Inc), Sales Contracts (Abbott Laboratories)
Safety Issues. In order to ensure that both Parties are provided with an adequate opportunity to review safety matters, the Parties shall mutually agree after the Effective Date on procedures with respect to (i) regulatory reporting requirements, (ii) the review of Product labeling, (iii) maintenance of a safety database and (iv) other safety issues.. CONFIDENTIAL TREATMENT REQUESTED
Appears in 2 contracts
Sources: Sales, Distribution, and Development Agreement (Abbott Laboratories), Sales, Distribution, and Development Agreement (Supergen Inc)
Safety Issues. In order to ensure that both Parties are provided with an adequate opportunity to review safety matters, the Parties shall mutually agree after the Effective Date on procedures with respect to (i) regulatory reporting requirements, (ii) the review of Product labeling, (iii) maintenance of a safety database and (iv) other safety issues.. 41 <PAGE> CONFIDENTIAL TREATMENT REQUESTED 10.3
Appears in 1 contract